Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H19ClO3 |
| Molecular Weight | 294.773 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCC(=O)C1=CC=C(C2CCCCC2)C(Cl)=C1
InChI
InChIKey=IJTPQQVCKPZIMV-UHFFFAOYSA-N
InChI=1S/C16H19ClO3/c17-14-10-12(15(18)8-9-16(19)20)6-7-13(14)11-4-2-1-3-5-11/h6-7,10-11H,1-5,8-9H2,(H,19,20)
| Molecular Formula | C16H19ClO3 |
| Molecular Weight | 294.773 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/4614821
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4614821
Bucloxic acid, a nonsteroidal anti-inflammatory agent, which was studied to treat the chronic glomerular nephropathy.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [A new nonsteroidal anti-inflammatory agent: bucloxic acid (804 CB)]. | 1974-09 |
|
| [Pharmacologic properties of a new, nonsteroidal anti-inflammatory agent, bucloxic acid (804 CB)]. | 1974-09 |
|
| Toxicological studies of bucloxic acid (804 CB). | 1974-09 |
|
| Study of possible teratogenicity of bucloxic acid (804 CB). | 1974-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:24 GMT 2025
by
admin
on
Mon Mar 31 18:22:24 GMT 2025
|
| Record UNII |
KV89R7ELF8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3251
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
KV89R7ELF8
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
100000085866
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
32808-51-8
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
DTXSID5022695
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
m90
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB05949MIG
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
C72087
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
C100223
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
251-231-0
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
93159
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL1697824
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY | |||
|
417
Created by
admin on Mon Mar 31 18:22:24 GMT 2025 , Edited by admin on Mon Mar 31 18:22:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |